The acute loss of taste and smell following COVID-19 are hallmark symptoms that affect 20–
85% of patients. However, the pathophysiology and potential treatments of COVID-19 smell …

The year 2020 became the year of the outbreak of coronavirus, SARS-CoV-2, which
escalated into a worldwide pandemic and continued into 2021. One of the unique symptoms …

This study prospectively assessed the 6-month prevalence of self-reported and
psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID …

Background Multiple voluntary surveillance platforms were developed across the world in
response to the COVID-19 pandemic, providing a real-time understanding of population …

A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or
taste loss. The duration of the chemosensory impairment and predictive factors of recovery …

The COVID-19 outbreak has spread extensively around the world. Loss of smell and taste
have emerged as main predictors for COVID-19. The objective of our study is to develop a …

Objectives To characterize longitudinal symptoms of mild coronavirus disease 2019 (COVID-
19) patients for a period of 6 months, to potentially aid in disease management. Methods …

Introduction: We evaluated the immunoglobulin (Ig) G antibody response against the
nucleocapsid protein (NP) and the receptor-binding domain (RBD) of the spike protein of …

Background The year 2020 was the year of the global COVID-19 pandemic. The severity of
the situation has become so substantial that many or even most of the patients with mild to …

Several studies have revealed either self-reported chemosensory alterations in large groups
or objective quantified chemosensory impairments in smaller populations of patients …